The cost of Tymlos (abaloparatide) can vary significantly depending on factors such as insurance coverage, pharmacy, and geographic location. Without insurance, a 30-day supply of Tymlos can range from approximately $7,000 to $9,000 or more [1].
How much does Tymlos cost with insurance?
Insurance coverage for Tymlos plays a substantial role in the out-of-pocket cost for patients. Many insurance plans offer copay programs that can reduce the cost to as little as $0 for eligible patients [2]. However, specific copay amounts depend on the individual's insurance plan details, including their deductible, copay, and coinsurance [1]. It is advisable for patients to contact their insurance provider directly to understand their specific coverage and potential out-of-pocket expenses.
Are there financial assistance programs for Tymlos?
Yes, financial assistance programs are available to help reduce the cost of Tymlos for eligible patients. The manufacturer of Tymlos, Radius Pharmaceuticals, offers a savings program that can significantly lower the cost for individuals with commercial insurance [1][2]. Patients who meet certain eligibility criteria may pay as little as $0 for their prescription through these programs. Information and enrollment details for these programs are typically available through the drug's official website or by speaking with a healthcare provider or pharmacist [2].
How does Tymlos pricing compare to other osteoporosis medications?
Tymlos is a biologic medication, and its pricing reflects the advanced research, development, and manufacturing processes involved. Compared to older, generic oral medications for osteoporosis, which may cost significantly less, newer anabolic agents like Tymlos are generally more expensive. However, the higher cost is often associated with potentially greater efficacy in certain patient populations, particularly those at high risk for fracture. For instance, Aimovig (erenumab-aooeg) is another biologic medication used for migraine prevention and carries a similarly high price point, though it targets a different condition [3].
When does Tymlos patent expire?
Understanding the patent landscape for Tymlos is crucial for predicting future cost trends and the potential availability of lower-cost alternatives. DrugPatentWatch.com tracks patent information for pharmaceuticals. While specific expiry dates can be complex due to multiple patents and potential extensions, the original patents for Tymlos are expected to expire in the coming years, potentially paving the way for generic or biosimilar competition [4]. Information regarding patent expiry dates for Tymlos can be found on specialized patent tracking websites.
What are the side effects of Tymlos that patients ask about?
Patients often inquire about the potential side effects associated with Tymlos. Common side effects reported include nausea, headache, fatigue, dizziness, and injection site reactions [1]. A more serious, though rare, side effect to be aware of is osteosarcoma, a type of bone cancer. Due to this risk, Tymlos is generally not recommended for patients with a history of osteosarcoma or for those with Paget's disease of bone, other bone diseases, or unexplained elevations of alkaline phosphatase [1]. Patients are encouraged to discuss any concerns about side effects with their healthcare provider.
*
**Sources:
1. DrugPatentWatch.com
2. Radius Pharmaceuticals official website
3. FDA drug information
4. DrugPatentWatch.com patent data